Dr. Rispah Chomba

Rispah Chomba is a South African infectious diseases researcher whose work centers on the epidemiology, clinical outcomes, and management of severe fungal and bacterial infections, particularly in high HIV-burden settings. Affiliated with national surveillance and academic hospital networks, contributions align closely with initiatives led by the National Institute for Communicable Diseases and major tertiary institutions in South Africa.

Research focuses on cryptococcal meningitis, Candida auris outbreaks, and acute bacterial meningitis, with emphasis on molecular epidemiology, antimicrobial resistance, and mortality reduction. Publications in leading infectious disease journals highlight the impact of flucytosine-based regimens, cryptococcal antigen screening, and genomic surveillance in improving patient outcomes and informing national treatment guidelines.

Additional work addresses antimicrobial stewardship and viral dynamics in immunocompromised populations, including prolonged SARS-CoV-2 shedding among people living with HIV. Across studies, strengths include large-scale surveillance analysis, clinically relevant policy translation, and advancing evidence-based care for vulnerable populations in resource-limited contexts.